Cortisol is a potent modulator of lipopolysaccharide-induced interferon signaling in macrophages

Innate Immunity

Volumn 17, Issue 3, 2011, Pages 302-320

  Billing, Anja M ^a,b   Fack, Fred ^a   Turner, Jonathan D ^a,b   Muller, Claude P ^a,b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITY OF TRIER   (Germany)

Author keywords

2 D DIGE; cortisol; FKBP51; IRF3; LPS; MX1

Indexed keywords

CHAPERONE; CYTOSKELETON PROTEIN; HYDROCORTISONE; INTERFERON; INTERFERON REGULATORY FACTOR 3; LIPOPOLYSACCHARIDE; STEROID;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MACROPHAGE; MONOCYTE; PROTEIN ANALYSIS; PROTEOMICS; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 79958791383     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425910369269     Document Type: Article

References (71)

1. Rickard AJ, Funder JW, Fuller PJ et al. The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis. Endocrinology 2006 ; 147: 5901-5906. (Pubitemid 44833507)
2. Barish GD, Downes M., Alaynick WA et al. A nuclear receptor atlas: macrophage activation. Mol Endocrinol 2005 ; 19: 2466-2477. (Pubitemid 41362661)
3. Hoebe K., Janssen EM, Kim SO et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003 ; 4: 1223-1229. (Pubitemid 37540691)
4. Galon J., Franchimont D., Hiroi N. et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002 ; 16: 61-71. (Pubitemid 34027951)
5. Ehrchen J., Steinmuller L., Barczyk K. et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 2007 ; 109: 1265-1274. (Pubitemid 46220679)
6. Fong CC, Zhang Y., Zhang Q. et al. Dexamethasone protects RAW264.7 macrophages from growth arrest and apoptosis induced by H2O2 through alteration of gene expression patterns and inhibition of nuclear factor-kappa B (NF-kappaB) activity. Toxicology 2007 ; 236: 16-28. (Pubitemid 46777065)
7. Liu YZ, Dvornyk V., Lu Y. et al. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem 2005 ; 280: 29011-29016. (Pubitemid 41161349)
8. MacKenzie S., Iliev D., Liarte C. et al. Transcriptional analysis of LPS-stimulated activation of trout (Oncorhynchus mykiss) monocyte/macrophage cells in primary culture treated with cortisol. Mol Immunol 2006 ; 43: 1340-1348. (Pubitemid 43356374)
9. Ogawa S., Lozach J., Benner C. et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 2005 ; 122: 707-721. (Pubitemid 41242636)
10. Kang JH, Kim HT, Choi MS et al. Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics 2006 ; 6: 1261-1273.
11. Mouithys-Mickalad A., Deby-Dupont G., Mathy-Hartert M. et al. Effects of glucocorticoids on the respiratory burst of Chlamydiaprimed THP-1 cells. Biochem Biophys Res Commun 2004 ; 318: 941-948. (Pubitemid 38625865)
12. Livak KJ, Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 ; 25: 402-408. (Pubitemid 34164012)
13. Billing AM, Fack F., Renaut J. et al. Proteomic analysis of the cortisol-mediated stress response in THP-1 monocytes using DIGE technology. J Mass Spectrom 2007 ; 42: 1433-1444. (Pubitemid 350113461)
14. Honke K., Wada Y. Regulation of vimentin expression and protease-mediated vimentin degradation during differentiation of human monocytic leukemia cells. Jpn J Cancer Res 1997 ; 88: 484-491. (Pubitemid 27267611)
15. Verhoeckx KC, Bijlsma S., de Groene EM et al. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 2004 ; 4: 1014-1028. (Pubitemid 38450707)
16. Haller O., Staeheli P., Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 2007 ; 89: 812-818. (Pubitemid 47001645)
17. Fleckner J., Rasmussen HH, Justesen J. Human interferon gamma potently induces the synthesis of a 55-kDa protein (gamma 2) highly homologous to rabbit peptide chain release factor and bovine tryptophanyl-tRNA synthetase. Proc Natl Acad Sci USA 1991 ; 88: 11520-11524. (Pubitemid 21916073)
18. Fleckner J., Martensen PM, Tolstrup AB et al. Differential regulation of the human, interferon inducible tryptophanyltRNA synthetase by various cytokines in cell lines. Cytokine 1995 ; 7: 70-77.
19. O'Connor JC, Lawson MA, Andre C. et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009 ; 14: 511-522.
20. De Miguel F., Lee SO, Onate SA et al. Stat3 enhances transactivation of steroid hormone receptors. Nucl Recept 2003 ; 1: 3.
21. Lou YJ, Pan XR, Jia PM et al. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Cancer Res 2009 ; 69: 3673-3680.
22. Huang X., Shen N., Bao C. et al. Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells. Arthritis Res Ther 2008 ; 10: R91.
23. Ossendorp F., Fu N., Camps M. et al. Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. J Immunol 2005 ; 174: 7815-7822. (Pubitemid 40806290)
24. Miettinen M., Sareneva T., Julkunen I. et al. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun 2001 ; 2: 349-355. (Pubitemid 33674248)
25. Zarember KA, Godowski PJ Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002 ; 168: 554-561. (Pubitemid 34049553)
26. O'Neill LA, Bowie AG The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007 ; 7: 353-364. (Pubitemid 46674493)
27. Lin R., Heylbroeck C., Pitha PM et al. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear trans-location, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 1998 ; 18: 2986-2996. (Pubitemid 28183468)
28. Debbas V., Arai RJ, Ferderbar S. et al. Regulation of p21Waf1 expression and TNFalpha biosynthesis by glutathione modulators in PMA induced-THP1 differentiation: involvement of JNK and ERK pathways. Biochem Biophys Res Commun 2007 ; 363: 965-970. (Pubitemid 47552977)
29. Kang SS, Woo SS, Im J. et al. Human placenta promotes IL-8 expression through activation of JNK/SAPK and transcription factors NF-kappaB and AP-1 in PMA-differentiated THP-1 cells. Int Immunopharmacol 2007 ; 7: 1488-1495. (Pubitemid 47307434)
30. Kim WJ, Bae EM, Kang YJ et al. Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 2006 ; 119: 421-429.
31. Knowles HJ, Mole DR, Ratcliffe PJ et al. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res 2006 ; 66: 2600-2607.
32. Plattner VE, Ratzinger G., Engleder ET et al. Alteration of the glycosylation pattern of monocytic THP-1 cells upon differentiation and its impact on lectin-mediated drug delivery. Eur J Pharm Biopharm 2009 ; 73: 324-330.
33. Ueki K., Tabeta K., Yoshie H. et al. Self-heat shock protein 60 induces tumour necrosis factor-alpha in monocyte-derived macrophage: possible role in chronic inflammatory periodontal disease. Clin Exp Immunol 2002 ; 127: 72-77. (Pubitemid 34155460)
34. Zhou J., Zhu P., Jiang JL et al. Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1. BMC Cell Biol 2005 ; 6: 25.
35. Kitamura D., Kaneko H., Miyagoe Y. et al. Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. Nucleic Acids Res 1989 ; 17: 9367-9379. (Pubitemid 20003196)
36. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol 2009 ; 85: 905-910.
37. Ishii K., Kurita-Taniguchi M., Aoki M. et al. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy. Immunol Lett 2005 ; 98: 280-290. (Pubitemid 40602641)
38. Thomas KE, Galligan CL, Newman RD et al. Contribution of interferon-beta to the murine macrophage response to the Toll-like receptor 4 agonist, lipopolysaccharide. J Biol Chem 2006 ; 281: 31119-31130. (Pubitemid 44582166)
39. Malcolm KC, Worthen GS Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors. J Biol Chem 2003 ; 278: 15693-15701. (Pubitemid 36799680)
40. Liu J., Shue E., Ewalt KL et al. A new gamma-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase. Nucleic Acids Res 2004 ; 32: 719-727. (Pubitemid 38263063)
41. Tolstrup AB, Bejder A., Fleckner J. et al. Transcriptional regulation of the interferon-gamma-inducible tryptophanyl-tRNA synthetase includes alternative splicing. J Biol Chem 1995 ; 270: 397-403.
42. Lee GK, Park HJ, Macleod M. et al. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 2002 ; 107: 452-460. (Pubitemid 36693650)
43. Fujigaki S., Saito K., Sekikawa K. et al. Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur J Immunol 2001 ; 31: 2313-2318. (Pubitemid 32785349)
44. Grohmann U., Volpi C., Fallarino F. et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 2007 ; 13: 579-586. (Pubitemid 46828479)
45. Turck J., Oberdorfer C., Vogel T. et al. Enhancement of antimicrobial effects by glucocorticoids. Med Microbiol Immunol 2005 ; 194: 47-53.
46. Kataoka N., Diem MD, Kim VN et al. Magoh, a human homolog of Drosophila mago nashi protein, is a component of the splicing-dependent exon-exon junction complex. EMBO J 2001 ; 20: 6424-6433. (Pubitemid 33078715)
47. Auboeuf D., Honig A., Berget SM et al. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 2002 ; 298: 416-419. (Pubitemid 35176350)
48. Eggert M., Michel J., Schneider S. et al. The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U. J Biol Chem 1997 ; 272: 28471-28478. (Pubitemid 27517795)
49. Eggert H., Schulz M., Fackelmayer FO et al. Effects of the heterogeneous nuclear ribonucleoprotein U (hnRNP U/SAF-A) on glucocorticoid-dependent transcription in vivo. J Steroid Biochem Mol Biol 2001 ; 78: 59-65. (Pubitemid 32786787)
50. Chen W., Srinath H., Lam SS et al. Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3. J Mol Biol 2008 ; 379: 251-260.
51. Clark K., Plater L., Peggie M., Cohen P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J Biol Chem 2009 ; 284: 14136-14146.
52. Servant MJ, Grandvaux N., tenOever BR Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J Biol Chem 2003 ; 278: 9441-9447. (Pubitemid 36800435)
53. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 2007 ; 282: 15325-15329. (Pubitemid 47093257)
54. Noyce RS, Collins SE, Mossman KL Differential modification of interferon regulatory factor 3 following virus particle entry. J Virol 2009 ; 83: 4013-4022.
55. Andersen J., VanScoy S., Cheng TF et al. IRF-3-dependent and augmented target genes during viral infection. Genes Immun 2008 ; 9: 168-175. (Pubitemid 351351658)
56. Annane D., Bellissant E., Bollaert PE et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009 ; 301: 2362-2375.
57. Annetta M., Maviglia R., Proietti R. et al. Use of corticosteroids in critically ill septic patients: a review of mechanisms of adrenal insufficiency in sepsis and treatment. Curr Drug Targets 2009 ; 10: 887-894.
58. Sprung CL, Annane D., Keh D. et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008 ; 358: 111-124.
59. Karaghiosoff M., Steinborn R., Kovarik P. et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 2003 ; 4: 471-477. (Pubitemid 36592440)
60. Sakaguchi S., Negishi H., Asagiri M. et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 2003 ; 306: 860-866. (Pubitemid 36776210)
61. Hwang SY, Hertzog PJ, Holland KA et al. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci USA 1995 ; 92: 11284-11288.
62. Jung ID, Lee MG, Chang JH et al. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock. J Immunol 2009 ; 182: 3146-3 154.
63. Suh HS, Zhao ML, Rivieccio M. et al. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response. J Virol 2007 ; 81: 9838-9850. (Pubitemid 350067687)
64. Huttunen R., Syrjanen J., Aittoniemi J. et al. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients. Shock 2010 ; 33: 149-154.
65. Bornstein SR, Zacharowski P., Schumann RR et al. Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc Natl Acad Sci USA 2004 ; 101: 16695-16700. (Pubitemid 39557775)
66. Zacharowski K., Zacharowski PA, Koch A. et al. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci USA 2006 ; 103: 6392-6397.
67. Tran N., Koch A., Berkels R. et al. Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J Clin Endocrinol Metab 2007 ; 92: 2773-2783. (Pubitemid 47037389)
68. Wurfel MM, Gordon AC, Holden TD et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008 ; 178: 710-720.
69. Schaaf B., Luitjens K., Goldmann T. et al. Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytes. Diagn Pathol 2009 ; 4: 12.
70. Buwitt-Beckmann U., Heine H., Wiesmuller KH et al. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 2006 ; 281: 9049-9057. (Pubitemid 43864617)
71. Chamorro S., Garcia-Vallejo JJ, Unger WW et al. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J Immunol 2009 ; 183: 2984-2994.